Le Lézard
Classified in: Health, Science and technology
Subject: FVT

Heart Failure Prevention: Early Detection Matters, Upcoming Webinar Hosted by Xtalks


In this free webinar, gain a better understanding of the stages of heart failure and why early detection is essential for improving patient outcomes. Attendees will learn about the current guidelines for the detection and management of heart disease. The featured speakers will discuss advances in care delivery for heart disease and how bringing diagnostics to patient-centric locations, including the home, positively impacts patient experience. The speakers will discuss how new models of healthcare delivery can be incorporated into everyday patient care and population health strategy.

TORONTO, March 26, 2024 /PRNewswire-PRWeb/ -- In the United States, the healthcare industry is reactive, focused on treating diseases that have already manifested and are driving individuals to seek care. But what if we turned this reactive approach into one that is proactive, focused on catching diseases earlier when the patient's prognosis is exponentially better? Structural and functional heart disease, as seen in heart failure, is a prime example of how early disease detection can greatly improve patient outcomes.

Access to screening tools such as echocardiograms and those qualified to perform these exams is low and continues to decrease.

Heart disease is the leading cause of death in the United States: approximately 6.7 million Americans over the age of 20 experience heart failure, with this number expected to rise to 8.5 million by 2030. As heart failure progresses through its stages from A to D, the prognosis for patients rapidly declines. Therefore, there is an important need to detect and manage heart disease earlier before patients become symptomatic. However, access to screening tools such as echocardiograms and those qualified to perform these exams is low and continues to decrease.

In this webinar, the featured speakers will explore the barriers to screening access that impact physicians' abilities to diagnose structural heart disease earlier. The speakers will also share how these barriers can be overcome by offering screening services in more patient-centric locations by leveraging artificial intelligence (AI)-guided ultrasound.

Register for this webinar today to learn about advances in healthcare delivery for heart failure prevention.

Join Erik Abel, PharmD, MBA, VP, Clinical Strategy & Innovation, Ultrasound Digital Solution ? Caption Care; Daniel Bensimhon, MD, Medical Director Advanced HF & Mechanical Support Program, Cone Health; and Jason Swartz, President, Central Region, agilon health, for the live webinar on Tuesday, April 16, 2024, at 1pm EDT (10am PDT).

For more information, or to register for this event, visit Heart Failure Prevention: Early Detection Matters.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit https://xtalks.com
For information about hosting a webinar visit https://xtalks.com/why-host-a-webinar/

Media Contact

Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected], http://www.xtalks.com 

SOURCE Xtalks


These press releases may also interest you

26 avr 2024
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

26 avr 2024
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

26 avr 2024
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

26 avr 2024
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

26 avr 2024
David J. Dykeman, co-chair of the Life Sciences & Medical...

26 avr 2024
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: